Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection

被引：0
|
作者：
Saifur Rahman
Zafar K Khan
Brian Wigdahl
Stephen Jennings
Frederic Tangy
Pooja Jain
机构：
[1] Drexel University College of Medicine,Drexel Institute for Biotechnology and Virology Research, and the Department of Microbiology and Immunology
来源：
Retrovirology | / 11卷 / Suppl 1期
关键词：
Spastic Paraparesis; Proviral Integration; Early Immune Response; Multiplex Cytokine; Cell Leukemia Virus Type;
D O I：
10.1186/1742-4690-11-S1-P70
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Flt3 ligand: A novel dendritic cell (DC) stimulating cytokine that induces tumor regression and anti-tumor immune responses in vivo.
    Lynch, DH
    Andreasen, A
    Miller, RE
    Schuh, JCL
    BLOOD, 1996, 88 (10) : 1737 - 1737
  • [42] Human T-Cell Leukemia Virus Type 1 Infection Is a Risk Factor for Atherosclerosis
    Takeoka, Hiroaki
    Sagara, Yasuko
    Ksashiwagi, Seizaburo
    Nabeshima, Shigeki
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (03): : 164 - 169
  • [43] Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation
    Yamauchi, Junji
    Yamano, Yoshihisa
    Yuzawa, Kenji
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (03): : 296 - 298
  • [44] Dendritic Cell Homeostasis Is Maintained by Non-Hematopoietic and T Cell-Produced Flt3-Ligand In Steady-State and During Immune Responses
    Boddupalli, Chandra Sekhar
    Baumjohann, Dior
    Sparwasser, Tim
    Manz, Markus G.
    BLOOD, 2010, 116 (21) : 658 - 658
  • [45] Mechanism of murine Vγ1+ γδ T cell-mediated innate immune response against Listeria monocytogenes infection
    Matsuzaki, G
    Yamada, H
    Kishihara, K
    Yoshikai, Y
    Nomoto, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 928 - 935
  • [46] A dendritic cell targeting NY-ESO-1 vaccine significantly augments early and durable immune responses in melanoma patients pretreated with human Flt-3 Ligand
    Bhardwaj, Nina
    Friedlander, Philip
    Pavlick, Anna
    Ernstoff, Marc
    Gastman, Brian
    Hanks, Brent
    Albertini, Mark
    Luke, Jason
    Yellin, Michael
    Keler, Tibor
    Davis, Thomas
    Vitale, Laura
    Blazquez, Ana
    Morishima, Chihiro
    Danaher, Patrick
    Warren, Sarah
    Salim, Bob
    Hess, Bruce
    D'Amico, Leonard
    Lundgren, Lisa
    Disis, Nora
    Cheever, Martin
    Fling, Steven
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] Multiple T-Cell Responses to Human Immunodeficiency Virus Type 1 Are Enhanced by Dendritic Cells
    Huang, Xiao-Li
    Fan, Zheng
    Borowski, LuAnn
    Rinaldo, Charles R.
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (10) : 1504 - 1516
  • [48] Antibodies to the Envelope Glycoprotein of Human T Cell Leukemia Virus Type 1 Robustly Activate Cell-Mediated Cytotoxic Responses and Directly Neutralize Viral Infectivity at Multiple Steps of the Entry Process
    Kuo, Chien-Wen S.
    Mirsaliotis, Antonis
    Brighty, David W.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (01): : 361 - 371
  • [49] Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells (vol 93, pg 760, 2002)
    Sun, BL
    Nitta, T
    Shoda, M
    Tanaka, M
    Hanai, S
    Hoshino, H
    Miwa, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (08): : 952 - 952
  • [50] HUMAN IMMUNE-RESPONSE TO ACTIVE IMMUNIZATION WITH RAUSCHER LEUKEMIA-VIRUS .1. CELL-MEDIATED AND CELL-ASSOCIATED IMMUNITY
    HERSH, EM
    GUTTERMAN, JU
    MAVLIGIT, G
    GSCHWIND, CR
    FREIREICH, EJ
    LEVINE, PH
    PLATA, EJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (02): : 317 - 325
12345